SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Cryogenic Logistics Company CryoPort Grabs Contrac
Business
Cryogenic Logistics Company CryoPort Grabs Contracts for Gilead, Novartis CAR-T Products
CryoPort handles the products for more than 172 of the more than 800 immunotherapy trials underway.
November 1, 2017
 · 
3 min read
 · 
Alex Keown
Gilead's $12B Bet Pays Off in Two Months After the
Business
Gilead HCV Woes Continue and Investors are Spooked
Gilead continues to see serious revenue declines in its hepatitis C marketshare, a space it has dominated for several years.
October 26, 2017
 · 
2 min read
 · 
Alex Keown
Gilead's $12B Bet Pays Off in Two Months After the
Drug Development
Gilead Shows Off Mid-Stage NASH Data
Gilead released results from a Phase II clinical trial of GS-0976 for NASH.
October 24, 2017
 · 
2 min read
 · 
Mark Terry
Gemini Therapeutics Banks $42.5M to Bring Precisio
BioMidwest
These 3 Gene Therapy Biotechs Could Make Investors Rich
Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze.
October 23, 2017
 · 
3 min read
 · 
Mark Terry
Gilead's $12B Bet Pays Off in Two Months After the
FDA
Gilead’s $12B Bet Pays Off in Two Months After the FDA Approves Kite’s Revolutionary CAR-T Therapy
Maybe timing is everything. On Aug. 28, 2017, Gilead acquired Kite for about $11.9B.
October 18, 2017
 · 
3 min read
 · 
Mark Terry
Biotech Bay
Are Analysts Secretly Calling Gilead A Screaming Buy?
October 13, 2017
 · 
1 min read
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
Business
How Much Cash Kite Pharma’s Execs Made From Its $12 Billion Gilead Deal
September 29, 2017
 · 
2 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Biotech Bay
Why Booming Vertex is on Its Way to Becoming Gilead’s Mini-Me
September 28, 2017
 · 
3 min read
Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit
Policy
Big Pharma Edgy After Revival of Gilead’s Whistleblower Lawsuit
September 27, 2017
 · 
2 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Gilead Prices $3 Billion of Senior Unsecured Notes
May 14, 2026
 · 
3 min read
Press Releases
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026
May 14, 2026
 · 
13 min read
Press Releases
Gilead Sciences Announces First Quarter Financial Results
May 8, 2026
 · 
19 min read
Press Releases
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
May 8, 2026
 · 
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
May 1, 2026
 · 
1 min read
Press Releases
U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
April 29, 2026
 · 
12 min read
Press Releases
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
April 28, 2026
 · 
7 min read
Press Releases
Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
April 23, 2026
 · 
1 min read
Press Releases
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
April 17, 2026
 · 
8 min read
Press Releases
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
 · 
6 min read
Load More